Skip to main content
SpringerLink
Log in

An Innovatory GABA Receptor Modulator and Liver Oxidase System Microsomal Cytochrome P450 Activator in Patients with Alcoholism

  • Published:
Pharmaceutical Chemistry Journal Aims and scope

Molecular docking studies (in Schrödinger and Glide software) showed that the molecule m-Cl-BHU (meta-chlorobenzhydrylurea) is complementary to the benzodiazepine binding site of GABAA receptors. Binding energy was low (-11.14 kcal/mol); m-Cl-BHU interacts with the key amino acids at the α1γ2 interface: Tyr159, Tyr209, and H101 Phe77 with high fit to the dG insertion model: 0.741. Binding of [3H]flunitrazepam with the benzodiazepine site of brain GABAA receptors increased in rats with experimental alcoholism treated with m-Cl-BHU at a dose of 100 mg/kg for 14 days. Changes in pharmacokinetic parameters (T1/2, Clt, MRT, MET, and AUC) of the model substrate antipyrine in saliva were seen in healthy volunteers and male patients with alcoholism using Galodif (m-Cl-BHU) at a dose of 300 mg/day for 21 days. Elimination of antipyrine in patients with alcoholism was increased due to activation of microsomal cytochrome P450 in the liver oxidase system.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1.
Fig. 2.
Fig. 3.
Fig. 4.
Fig. 5.
Fig. 6.
Fig. 7.
Fig. 8.
Fig. 9.

Similar content being viewed by others

References

  1. T. A. Voronina and S. B. Seredenin, Methodological Recommendations for the Study of Tranquilizer (Anxiolytic) Actions of Pharmacological Substances. Guidelines for Experimental (Preclinical) Study of Novel Pharmacological Substances [in Russian], Remedium, Moscow (2005), pp. 126 – 136.

    Google Scholar 

  2. N. L. Shimanovskii, M. A. Epinetov, and M. Ya. Mel’nikov, Molecular and Nanopharmacology [in Russian], Fizmatlit, Moscow, (2009).

    Google Scholar 

  3. R. Cossart, C. Bernard, and Y. Ben-Ary, Trends Neurosci., No. 2, 108 – 115 (2005).

    Article  Google Scholar 

  4. A. Winkelmann, N. Maggio, J. Eller, et al., J. Clin. Invest., 124, 696 – 711 (2014).

    Article  CAS  Google Scholar 

  5. A. Dixon, H. Morris, G. Breen, et al., Proc. Natl. Acad. Sci. USA, 107(5), 2289 – 2294 (2010).

    Article  CAS  Google Scholar 

  6. R. W. Olsen and J. Liang, Mol. Brain, 10, 45 (2017).

    Article  Google Scholar 

  7. R. Olsen, Proc. Natl. Acad. Sci. USA, 108(12), 4699 – 4700 (2011).

    Article  CAS  Google Scholar 

  8. M. Enoch, Pharmacol. Biochem. Behav., 90(1), 95 – 104 (2008).

    Article  CAS  Google Scholar 

  9. S. Roh, S. Matsushita, S. Hara, et al., Alcohol Clin. Exp Res., 35(3), 400 – 407 (2011).

    Article  CAS  Google Scholar 

  10. A. Lindemeyer, Y. Shen, and F. Yazdani, Mol. Pharmacol., 92(2), 101 – 12 (2017).

    Article  Google Scholar 

  11. N. A. Bokhan, A. I. Mandel’, S. A. Ivanova, et al., Voprosy Narkol., No. 1, 26 – 62 (2017).

    Google Scholar 

  12. G. F. Koob and N. D. Volkow, Lancet Psychiatry, 3(8), 760 – 773 (2016).

    Article  Google Scholar 

  13. T. V. Shushpanova and A. V. Solonskii, Neurosci. Behav. Physiol., 43, 423 – 430 (2013).

    Article  CAS  Google Scholar 

  14. T. V. Shushpanova, J. Alcohol Drug Depend., No. 2, 176 (2014); doi:https://doi.org/10.4172/2329-6488.1000176.

    Article  Google Scholar 

  15. T. V. Shushpanova, A. V. Solonskii, O. V. Shushpanova, Drug Addiction, F. Zhao (ed.), M. Li (coed.), IntechOpen, London, (2018), pp. 73 – 102; doi: https://doi.org/10.5772/intechopen.73333; doi: https://doi.org/10.5772/intechopen.70103.

  16. E. A. Frost, R. S. Gist, and F. Adriano, Int. Anesthesiol. Clin., 49(1), 119 – 133 (2011).

    Article  Google Scholar 

  17. C. Ikonomiou, P. Bittigau, M. J. Ishimaru, et al., Science, 287(5455), 1056 – 1060 (2000).

    Article  Google Scholar 

  18. R. Spanagel, Physiol. Rev., 89(2), 649 – 705 (2009).

    Article  CAS  Google Scholar 

  19. S. De Santis, A. Cosa-Linan, R. Garcia-Hernandez, et al., Sci. Adv., 24, 6(26), eaba0154 (2020).

  20. T. V. Shushpanova, Zh. Nevrol. Psikhiat. im. S. S. Korsakova, 7(2), 122 – 124 (1989).

    Google Scholar 

  21. B. Ftsrstera, P. F. Castro, G. Moraga-Cid, and L. G. Aguayo, Front. Cell. Neurosci., 10, 114 (2016); doi: https://doi.org/10.3389/fncel.2016.00114.

    Article  Google Scholar 

  22. G. Addolorato, L. Leggio, F. W. Hopf, et al, Neuropsychopharmacology, 37, 163 – 177 (2012).

    Article  CAS  Google Scholar 

  23. J. F. Amundarain, F. Viso Zamarreso, A. Giorgetti, and M. Costabel, J. Biomol. Struct. Dynam., 37(6), 1597 – 1615 (2019).

    Article  CAS  Google Scholar 

  24. H. A. Lester, M. I. Dibas, D. S. Dahan, et al, Trends Neurosci., 27, 329 – 336 (2004).

    Article  CAS  Google Scholar 

  25. S. M. Sine and A. G. Engel, Nature, 440, 448 – 455 (2006).

    Article  CAS  Google Scholar 

  26. T. V. Shushpanova and V. Ya. Semke, Zh. Nevrol. Psikhiat. im. S. S. Korsakova, 106(11), 53 – 56 (2006).

    CAS  Google Scholar 

  27. T. V. Shushpanova, A. I. Mandel’, N. A. Bokhan, et al. Yakutskii Med Zh., 4(68), 113 – 117 (2019).

    Google Scholar 

  28. T. V. Shushpanova, N. A. Bokhan, V. F. Lebedeva, et al., J. Addict. Res. Ther., 7(2), 271 (2016).

    Google Scholar 

  29. B. Rikke, K. Kongsbak, P. L. Sshrensen, et al., PLoS One, 8, No. 1 (2013).

    Google Scholar 

  30. T. V. Shushpanova, T. P. Novozheeva, V. Ya. Semke, et al. Russian Patent RU 2155034 C1, August 27, 2000, Application No. 99125063/14 of November 29, 1999.

  31. V. Ya. Semke, T. V. Shushpanova, T. P. Novozheeva, et al., Russian Patent RU 2436573 S2, December 20, 2011, Application No. 2009128808/15 of July 27, 2009.

  32. R. Bergmann, K. Kongsbak, and P. L. Sorensen, PLoS One, 8(1), e52323 (2013).

    Article  CAS  Google Scholar 

  33. Schrödinger Release 2017-3: Schrödinger Suite 2017 – 3 Protein Preparation Wizard; Epik, Schrödinger, LLC, New York, NY, 2017; Impact, Schrödinger, LLC, New York, NY, 2017; LigPrep, Schrödinger, LLC, New York, NY, 2017; Prime, Schrödinger, LLC, New York, NY, 2017; QikProp, Schrödinger, LLC, New York, NY (2017).

  34. J. C. Shelley, A. Cholleti, L. L. Frye, et al., J. Comput. Aided Mol. Des., 21, 681 – 691 (2007).

    Article  CAS  Google Scholar 

  35. J. L. Friesner, J. L. Banks, R. B. Murphy, et al., J. Med. Chem., 47(7), 1739 – 1749 (2004).

    Article  CAS  Google Scholar 

  36. T. A. Halgren, R. B. Murphy, R. A. Friesner, J. Med. Chem., 47(7), 1750 – 1759 (2004).

    Article  CAS  Google Scholar 

  37. É. S. Gorshtein, A. V. Semenyuk, and A. Ya. Maiore,” Usp. Gepatol., 14, 128 – 147 (1988).

  38. K. Yamaoka, T. Nakagawa, and T. Uno, J. Pharmacokinet. Biopharm., 6(2), 165 – 175 (1978).

    Article  CAS  Google Scholar 

  39. V. K. Piotrovskii, Khim.-Farm. Zh., 18(7), 845 – 849 (1984).

    CAS  Google Scholar 

  40. Yu. B. Belousov and K. G. Gurevich, Clinical Pharmacokinetics. The Practice of Substance Dosing [in Russian], Khim.- Farm. Zh., special issue in the Rational Pharmacotherapy series, 54(11), (2005), Littera, Moscow.

    Google Scholar 

  41. G. Zaccara and E. Perucca, Epileptic Disord., 16(4), 409 – 431 (2014).

    Article  Google Scholar 

  42. C. Johannessen Landmark, Expert Rev. Neurother., 10(1), 119 – 140 (2005).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Science Research Institute of Mental Health, Tomsk National Medical Research Center, Russian Academy of Sciences, Tomsk, Russia

    T. V. Shushpanova, N. A. Bokhan, T. P. Novozheeva, A. I. Mandel’, E. D. Schastnyi & N. I. Kisel’

  2. Siberian State Medical University, Tomsk, Russia

    N. A. Bokhan

  3. Tomsk National Polytechnical Research University, Tomsk, Russia

    K. S. Stankevich & E. M. Knyazeva

  4. Mental Health Science Center, Moscow, Russia

    O. V. Shushpanova

  5. E. D. Goldberg Science Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Medical Research Center, Russian Academy of Sciences, Tomsk, Russia

    V. V. Udut, S. M. Safronov & R. S. Boev

Authors
  1. T. V. Shushpanova
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. N. A. Bokhan
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. K. S. Stankevich
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. T. P. Novozheeva
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. A. I. Mandel’
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. E. D. Schastnyi
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. N. I. Kisel’
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. O. V. Shushpanova
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. V. V. Udut
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. S. M. Safronov
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. R. S. Boev
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. E. M. Knyazeva
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to T. V. Shushpanova.

Additional information

Translated from Khimiko-Farmatsevticheskii Zhurnal, Vol. 54, No. 11, pp. 9 – 16, November, 2020.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Shushpanova, T.V., Bokhan, N.A., Stankevich, K.S. et al. An Innovatory GABA Receptor Modulator and Liver Oxidase System Microsomal Cytochrome P450 Activator in Patients with Alcoholism. Pharm Chem J 54, 1093–1100 (2021). https://doi.org/10.1007/s11094-021-02327-x

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11094-021-02327-x

Keywords

Search

Navigation